Integrin alpha 3 beta 1

Integrin alpha 3 beta 1

Integrin alpha 3 beta 1 Overview

Molecule Name
Integrin alpha 3/beta 1
Drug Development Progress
Drugs in Clinical Trials1
Approved Drugs0
Highest Development StagePhase 1 Clinical
Target Synonym
Background
Integrin alpha-3/beta-1 is a receptor for fibronectin, laminin, collagen, epiligrin, thrombospondin and CSPG4. Integrin alpha-3/beta-1 provides a docking site for FAP (seprase) at invadopodia plasma membranes in a collagen-dependent manner and hence may participate in the adhesion, formation of invadopodia and matrix degradation processes, promoting cell invasion. Alpha-3/beta-1 may mediate with LGALS3 the stimulation by CSPG4 of endothelial cells migration.

Integrin alpha 3 beta 1 Product List

Species
  • Cynomolgus(1)
  • Human(1)
  • Rat(1)
Tag
  • His Tag(3)
Host
  • HEK293(2)
  • CHO(1)
Conjugate
  • Unconjugated(3)
Grade
  • RUO(3)
Low Endotoxin
  • Yes(1)
  • No(2)

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
VAX-014VAX-014Phase 1 ClinicalVaxiion Therapeutics Llc
Solid tumours
Details
Customer Reviews